New and surprising insights into pathogenesis of multicentric squamous cancers in the female lower genital tract

Journal of the National Cancer Institute

Volumn 97, Issue 24, 2005, Pages 1798-1799

  Feng, Qinghua ^a   Kiviat, Nancy B ^a  

^a UNIVERSITY OF WASHINGTON   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CANCER INCIDENCE; CANCER INVASION; CANCER MORTALITY; CANCER RISK; CANCER SCREENING; CARCINOGENESIS; DISEASE PREDISPOSITION; EDITORIAL; FEMALE; FEMALE GENITAL TRACT CANCER; HUMAN; HYSTERECTOMY; PRIORITY JOURNAL; RECURRENT CANCER; RISK FACTOR; SECOND CANCER; SQUAMOUS CELL CARCINOMA; UTERINE CERVIX CANCER; UTERINE CERVIX CARCINOMA IN SITU; VAGINA CANCER; VERRUCA VULGARIS; VULVA CANCER; WART VIRUS;

CARCINOMA, SQUAMOUS CELL; CELL TRANSFORMATION, NEOPLASTIC; CERVICAL INTRAEPITHELIAL NEOPLASIA; CLONE CELLS; DNA, VIRAL; FEMALE; HUMAN PAPILLOMAVIRUS 16; HUMAN PAPILLOMAVIRUS 18; HUMANS; PAPILLOMAVIRIDAE; PAPILLOMAVIRUS INFECTIONS; UTERINE CERVICAL DYSPLASIA; UTERINE CERVICAL NEOPLASMS; VAGINAL NEOPLASMS; VULVAR NEOPLASMS;

EID: 29944443599     PISSN: 00278874     EISSN: 14602105     Source Type: Journal    
DOI: 10.1093/jnci/dji450     Document Type: Editorial

References (18)

1. Bosch FX, Manos MM, Munoz N, Sherman M, Jansen AM, Peto J, et al. Prevalence of human papillomavirus in cervical cancer: A worldwide perspective. International biological study on cervical cancer (IBSCC) Study Group. J Natl Cancer Inst 1995;87:796-802.
2. Walboomers JM, Jacobs MV, Manos MM, Bosch FX, Kummer JA, Shah KV, et al. Human papillomavirus is a necessary cause of invasive cervical cancer worldwide. J Pathol 1999;189:12-9.
3. Steenbergen RD, de Wilde J, Wilting SM, Brink AA, Snijders PJ, Meijer CJ. HPV-mediated transformation of the anogenital tract. J Clin Virol 2005; 32 Suppl 1:S25-33.
4. National Cancer Institute. Surveillance, Epidemiology, and End Results (SEER) Program. SEER*Stat Database: Incidence - SEER 9 Regs Public Use, Nov 2004 Sub (1973-2002). Surveillance Research Program, Cancer Statistics Branch, released April 2005, based on the November 2004 submission. Available at http://seen.cancer.gov (last accessed: October 24, 2005).
5. Brinton LA, Nasca PC, Mallin K, Schairer C, Rosenthal J, Rothenberg R, et al. Case-control study of in situ and invasive carcinoma of the vagina. Gynecol Oncol 1990;38:49-54.
6. Daling JR, Madeleine MM, Schwartz SM, Shera KA, Carter JJ, McKnight B, et al. A population-based study of squamous cell vaginal cancer: HPV and cofactors. Gynecol Oncol 2002;84:263-70.
7. Vinokurova S, Wentzensen N, Einenkel J, Klaes R, Ziegert C, Melsheimer P, et al. Clonal history of papillomavirus-induced dysplasia in the female lower genital tract. J Natl Cancer Inst 2005;97:1816-21.
8. el Hamidi A, Kocjan G, Du MQ. Clonality analysis of archival cervical smears. Correlation of monoclonality with grade and clinical behavior of cervical intraepithelial neoplasia. Acta Cytol 2003;47:117-23.
9. Ueda Y, Enomoto T, Miyatake T, Ozaki K, Yoshizaki T, Kanao H, et al. Monoclonal expansion with integration of high-risk type human papillomaviruses is an initial step for cervical carcinogenesis: association of clonal status and human papillomavirus infection with clinical outcome in cervical intraepithelial neoplasia. Lab Invest 2003;83:151-27.
10. Ueda Y, Enomoto T, Miyatake T, Shroyer KR, Yoshizaki T, Kanao H, et al. Analysis of clonality and HPV infection in benign, hyperplastic, premalignant, and malignant lesions of the vulvar mucosa. Am J Clin Pathol 2004;122:266-74.
11. Guo Z, Ponten F, Wilander E, Ponten J. Clonality of precursors of cervical cancer and their genetical links to invasive cancer Mod Pathol 2000; 13:606-13.
12. Larson AA, Liao SY, Stanbridge EJ, Cavenee WK, Hampton GM. Genetic alterations accumulate during cervical tumorigenesis and indicate a common origin for multifocal lesions. Cancer Res 1997;57:4171-6.
13. Guo Z, Hu X, Afink G, Ponten F, Wilander E, Ponten J. Comparison of chromosome 3p deletions between cervical precancers synchronous with and without invasive cancer. Int J Cancer 2000;86:518-23.
14. Girardi F, Pickel H, Beyer-Finkler E, Pfister H. Specific rearrangements of human papillomavirus DNA provide molecular evidence for genetic heterogeneity of primary cervical cancers, recurrences, and lymph node metastases in two patients. Gynecol Oncol 1993;51:281-6.
15. Enomoto T, Haba T, Fujita M, Hamada T, Yoshino K, Nakashima R, et al. Clonal analysis of high-grade squamous intra-epithelial lesions of the uterine cervix. Int J Cancer 1997;73:339-44.
16. Hu X, Pang T, Asplund A, Ponten J, Nister M. Clonality analysis of synchronous lesions of cervical carcinoma based on X chromosome inactivation polymorphism, human papillomavirus type 16 genome mutations, and loss of heterozygosity. J Exp Med 2002;195:845-54.
17. Chao C, Torosian MH, Boraas MC, Sigurdson ER, Hoffman JP, Eisenberg BL, et al. Local recurrence of breast cancer in the stereotactic core needle biopsy site: Case reports and review of the literature. Breast J 2001;7:124-7.
18. Herman JM, Homesley HD, Dignan MB. Is hysterectomy a risk factor for vaginal cancer? JAMA 1986;256:601-3.